CDKN2A and myotonic dystrophy type 1: Silencing of BRCA1 (Figure 6I) promoted a significant decrease in cell growth (Figure 6J) and an increase in p16INK4A and γ-H2AX levels in both control and DM1 fibroblasts (Figure 6, K and L, and Supplemental Figure 5E).